Please sign in to follow a disease.
Virtual reality calms nerves and lowers blood pressure in clinic
NCT ID NCT06960057
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a short, calming virtual reality (VR) experience could reduce blood pressure and anxiety in adults with suspected white coat hypertension—where blood pressure spikes due to clinic stress. Seventy-nine participants used a VR headset for 5 minutes during a clinic visit. Their blood pressure and anxiety were measured before and after. The goal is to see if VR can make clinic blood pressure readings more accurate and less stressful.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Virtual reality relaxation session
- What this could lead to
- If it works, this could offer a simple, drug-free way to reduce blood pressure spikes during clinic visits for people with white coat hypertension.
- What could go wrong
- This is a small, early-stage study with no control group, so results may not be conclusive. The effect may be temporary or not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
79 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older. * Undergoing ambulatory blood pressure monitoring (ABPM) at Mayo Clinic Florida for any clinical indication. * Able and willing to provide informed consent. Exclusion Criteria: * History of epilepsy or seizure disorders. * Significant cognitive impairment (e.g., dementia, Alzheimer's disease). * Significant visual impairment that prevents visualization of the VR environment. * History of vestibular disorders (e.g., Meniere's disease, chronic vertigo). * Unstable cardiovascular conditions (e.g., myocardial infarction within the past year). * Chronic hypoxemic respiratory failure requiring supplemental oxygen. * Cervical spine instability or injuries that could impair safe VR use. * Current pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ambulatory blood pressure monitoring are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Florida
Jacksonville, Florida, 32081, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressing six points on the body help older adults sleep?
- Can video games calm anxious teens?
- Can a group program teach teens to cope before therapy starts?
- Can a vegan diet shield police officers from heart disease?
- Can a Plant-Based diet program help patients lose weight and improve heart health?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?